Carbetocin
CAS No. 37025-55-1
Carbetocin( —— )
Catalog No. M20952 CAS No. 37025-55-1
Carbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 142 | In Stock |
|
| 50MG | 262 | In Stock |
|
| 100MG | 419 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarbetocin
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.
-
DescriptionCarbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.(In Vitro):Carbetocin is an agonist with about 10-fold lower affinity for the oxytocin receptor but with significantly higher stability and a longer duration of action. Carbetocin has higher affinity to the chimeric E1 receptor and especially to each of the combinations of E1 with the other extracellular domains, i.e. chimeric receptors E13 (Ki=13 nM), E123 (Ki=56 nM), and E1234 (Ki=37 nM).(In Vivo):Carbetocin (2-20 mg/kg; i.p.) has a significant effect of treatment on the percent time spent climbing, swimming and immobile.Carbetocin (1, 10,100 μg/rat, i.c.v.) reveals a dose-dependent increase in the percent time spent swimming and a corresponding reduction in immobility following acute administration of 100 μg/rat.
-
In VitroCarbetocin is an agonist with about 10-fold lower affinity for the oxytocin receptor but with significantly higher stability and a longer duration of action. Carbetocin has higher affinity to the chimeric E1 receptor and especially to each of the combinations of E1 with the other extracellular domains, i.e. chimeric receptors E13 (Ki=13 nM), E123 (Ki=56 nM), and E1234 (Ki=37 nM).
-
In VivoCarbetocin (2-20 mg/kg; i.p.) has a significant effect of treatment on the percent time spent climbing, swimming and immobile. Carbetocin (1, 10,100 μg/rat, i.c.v.) reveals a dose-dependent increase in the percent time spent swimming and a corresponding reduction in immobility following acute administration of 100 μg/rat. Animal Model:Male Sprague-Dawley rats weighing between 300 and 500 g Dosage:2, 6.4, 20 mg/kg Administration:IP; single dose Result:Increased climbing with 6.4 mg/kg and resulted in a significantly greater proportion of time spent swimming with 20 mg/kg.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOxytocin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number37025-55-1
-
Formula Weight988.16
-
Molecular FormulaC45H69N11O12S
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL (31.37 mM)
-
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Theunissen F J Lester C Pujar Y V . Current research on carbetocin and implications for prevention of postpartum haemorrhage[J]. Reproductive Health 2018 15(S1):94-.
molnova catalog
related products
-
GJ103
GJ103 sodium salt is an active analog of the read-through compound GJ072.
-
ASC-JM-17
ASC-JM-17 is an activator of both Nrf1 and Nrf2 proteins. ASC-JM17 acts on Nrf1, Nrf2 and Hsf1 to increase the expression of proteasome subunits, antioxidant enzymes and molecular chaperones.
-
D(+)-Glucuronic acid...
Glucuronic acid is a carboxylic acid and highly soluble in water. In humans glucuronic acid is often linked to toxic or poisonous substances to allow for subsequent elimination and to hormones to allow for easier transport.
Cart
sales@molnova.com